Giuseppe Curigliano

Address European Institute of Oncology
Division of Early Drug Development


Giuseppe Curigliano, MD, PhD, is the Head of the Division of Early Drug Development at European Institute of Oncology, in Milan, Italy.

He is a clinician and researcher specialising in early drug development for patients with solid tumours with a special commitment on breast cancer. He is also involved in translational research related to immunotherapy, precision medicine, and biomarker identification breast cancer models.

He is member of the Scientific Advisory Committee of the International Breast Cancer Study Group (IBCSG) and of the Breast International Group (BIG) Immune Task Force. 

He is founding member of/and scientific chair for the International Cardio-Oncology Society (ICOS). Dr Curigliano has been a member of the ESMO Press & Media Affairs Committee since 2015 and he is serving on the ESMO Women for Oncology, ESMO Membership and ESMO Global Policy Committees since 2016.

He served as the scientific chair of the IMPAKT meeting that was held in Brussels in 2014 and as the Breast Cancer (metastatic) Track Chair of the ESMO 2014 meeting in Madrid.

He is an ESMO Faculty Member for breast cancer and has served on the Program Scientific Committee of the St Gallen Conference since 2011.

He has contributed to over 210 peer-reviewed publications. He also serves on the European School of Oncology (ESO) faculty committee.